Table 8.
Comparison of patient characteristics between the BSC and TACE groups with C-P score 10 or 11, matched by propensity score.
| Background factors | BSC | TACE | p value |
|---|---|---|---|
| n=127 | n=127 | ||
| No. of Patients | No. of Patients | ||
| Age (years) | |||
| <60 | 38 | 32 | 0.3995 |
| ≥60 | 89 | 95 | |
| Sex | |||
| Male | 81 | 79 | 0.7949 |
| Female | 46 | 48 | |
| Hepatitis B and C virological status | |||
| B−, C+ | 83 | 86 | 0.4087 |
| B+, C− | 13 | 16 | |
| B+, C+ | 2 | 0 | |
| B−, C− | 26 | 21 | |
| Maximum tumor size (cm) | |||
| ≤2 | 58 | 58 | 0.9828 |
| 2.1–3.0 | 48 | 49 | |
| 3.1–5.0 | 21 | 20 | |
| No. of tumors | |||
| 1 | 84 | 85 | 0.8942 |
| 2–3 | 43 | 42 | |
| TNM stage | |||
| I | 39 | 36 | 0.6549 |
| II | 64 | 71 | |
| III | 24 | 20 | |
| Bilirubin (mg/dL) | |||
| <2.0 | 35 | 31 | 0.8488 |
| 2.0–3.0 | 43 | 45 | |
| >3.0 | 49 | 51 | |
| Albumin (g/dL) | |||
| >3.5 | 2 | 3 | 0.8886 |
| 2.8–3.5 | 41 | 42 | |
| <2.8 | 84 | 82 | |
| PT (%) | |||
| >70 | 7 | 10 | 0.7462 |
| 40–70 | 106 | 104 | |
| <40 | 14 | 13 | |
| Ascites | |||
| None | 34 | 32 | 0.8772 |
| Responsive | 50 | 54 | |
| Unresponsive | 43 | 41 | |
| Encephalopathy | |||
| None | 76 | 75 | 0.8867 |
| Mild | 43 | 42 | |
| Coma | 8 | 10 | |